RxDoctor Payments Data

Tosha Marquardt, PA

Physician Assistant · New Bern, NCNPI 1033103981

Payments from drug & device makers

$2,613in general payments, 2019–2025

Across 125 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$302
  • Collegium Pharmaceutical, Inc.$230
  • Boston Scientific$220
  • Abbott$177
  • Biotronik NRO, Inc.$143
  • AbbVie$140
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,613100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,613 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$88,939
Medicare patients
285
Services billed
1,720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl26$32,686
Xtampza ErOxycodone Myristate37$25,210
Nucynta ErTapentadol Hcl17$24,500
OxycontinOxycodone Hcl43$23,692
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen472$16,574
Hysingla ErHydrocodone Bitartrate13$11,264
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen260$7,898
Fentanyl49$7,506
Aimovig AutoinjectorErenumab-Aooe11$5,787
Oxycodone Hcl266$4,572
Buprenorphine33$4,569
Hydrocodone Bitartrate ErHydrocodone Bitartrate11$3,353
Pregabalin160$3,296
Lidocaine20$2,829
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine19$2,443

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er, Nucynta Er$230$82,39680 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl$12$5,68066 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in New Bern

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →